Author:
Pósfai Éva,Irsai Gábor,Illés Árpád,Méhes Gábor,Marton Imelda,Molnár Csaba,Csípő István,Baráth Sándor,Gergely Lajos
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Reference26 articles.
1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300. doi: 10.3322/caac.20073
2. Laszlo J, Grizzle J, Jonsson U, Rundles RW (1962) Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas. Cancer Chemother Rep 16:247–250
3. Liu WM, Meyer B, Dalgleish AG (2009) How immunotherapy can enhance the response to other modalities and improve outcome and quality of life. J BUON 14(Suppl 1):S103–S109
4. Ferrara F, Ravasio R (2008) Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma. Clin Drug Investig 28(1):55–65
5. Plosker GL, Figgitt DP (2003) Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs 63(8):803–843
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献